Follow us on:

Linkedin Facebook

November 28, 2025

Broker Ratings

Personalis, Inc. (PSNL) Stock Analysis: Navigating Challenges with Strategic Collaborations and Innovative Genomic Solutions

Broker Ratings

Nutex Health Inc. (NUTX) Investor Outlook: Analyzing the 239.90% Revenue Growth and 121.63% Upside Potential

Broker Ratings

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Unraveling a 129.98% Potential Upside

Broker Ratings

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 184.79% Potential Upside

Broker Ratings

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 71% Upside in the Biotech Sector

Broker Ratings

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Growth Amid a Challenging Landscape

Broker Ratings

Delcath Systems, Inc. (DCTH) Stock Analysis: A Closer Look at Its 131% Potential Upside

Broker Ratings

Enhabit, Inc. (EHAB) Stock Analysis: Assessing Growth Potential Amidst a 5.20% Upside

Broker Ratings

Kura Oncology, Inc. (KURA): Investor Outlook Reveals a Striking 175% Potential Upside

Broker Ratings

Semler Scientific Inc. (SMLR) Stock Analysis: A 217% Potential Upside That Intrigues Investors

Tern plc

A shift in how IoT is secured by default

KeyScaler 2025 transforms IoT security by automating trust across every device’s lifecycle, from onboarding to decommissioning, turning scalable connectivity and compliance into a built-in feature...
Broker Ratings

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Strong Buy Ratings and Impressive Revenue Growth Highlight Growth Potential

Broker Ratings

Investor Outlook: Arvinas, Inc. (ARVN) Navigates Challenges with Cutting-Edge Biotech Innovation

Broker Ratings

REGENXBIO Inc. (RGNX) Stock Analysis: A Biotech with 122.82% Potential Upside and Promising Clinical Pipeline

Broker Ratings

Butterfly Network, Inc. (BFLY) Stock Analysis: A Promising Upside of 27% in the Medical Device Arena

Broker Ratings

Ginkgo Bioworks Holdings, Inc. (DNA) Investor Outlook: Analyzing a 17% Potential Upside Amidst Market Challenges

Broker Ratings

Auna SA (AUNA) Stock Analysis: High Potential Upside with 123% Target Growth

Broker Ratings

Orthofix Medical Inc. (OFIX) Stock Analysis: 41% Potential Upside Beckons Investors

Broker Ratings

Evolus, Inc. (EOLS) Investor Outlook: Unveiling a 165% Potential Upside in the Performance Beauty Sector

Broker Ratings

Valneva SE (VALN) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

US Broker Ratings

Broker Ratings

Personalis, Inc. (PSNL) Stock Analysis: Navigating Challenges with Strategic Collaborations and Innovative Genomic Solutions

Broker Ratings

Nutex Health Inc. (NUTX) Investor Outlook: Analyzing the 239.90% Revenue Growth and 121.63% Upside Potential

Broker Ratings

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Unraveling a 129.98% Potential Upside

Broker Ratings

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 184.79% Potential Upside

Broker Ratings

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 71% Upside in the Biotech Sector

Broker Ratings

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Growth Amid a Challenging Landscape

Broker Ratings

Delcath Systems, Inc. (DCTH) Stock Analysis: A Closer Look at Its 131% Potential Upside

Broker Ratings

Enhabit, Inc. (EHAB) Stock Analysis: Assessing Growth Potential Amidst a 5.20% Upside

Broker Ratings

Kura Oncology, Inc. (KURA): Investor Outlook Reveals a Striking 175% Potential Upside

Broker Ratings

Semler Scientific Inc. (SMLR) Stock Analysis: A 217% Potential Upside That Intrigues Investors

Tern plc

A shift in how IoT is secured by default

KeyScaler 2025 transforms IoT security by automating trust across every device’s lifecycle, from onboarding to decommissioning, turning scalable connectivity and compliance into a built-in feature...
Broker Ratings

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Strong Buy Ratings and Impressive Revenue Growth Highlight Growth Potential

Broker Ratings

Investor Outlook: Arvinas, Inc. (ARVN) Navigates Challenges with Cutting-Edge Biotech Innovation

Broker Ratings

REGENXBIO Inc. (RGNX) Stock Analysis: A Biotech with 122.82% Potential Upside and Promising Clinical Pipeline

Broker Ratings

Butterfly Network, Inc. (BFLY) Stock Analysis: A Promising Upside of 27% in the Medical Device Arena

Broker Ratings

Ginkgo Bioworks Holdings, Inc. (DNA) Investor Outlook: Analyzing a 17% Potential Upside Amidst Market Challenges

Broker Ratings

Auna SA (AUNA) Stock Analysis: High Potential Upside with 123% Target Growth

Broker Ratings

Orthofix Medical Inc. (OFIX) Stock Analysis: 41% Potential Upside Beckons Investors

Broker Ratings

Evolus, Inc. (EOLS) Investor Outlook: Unveiling a 165% Potential Upside in the Performance Beauty Sector

Broker Ratings

Valneva SE (VALN) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector

Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

November 28, 2025

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple